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Abstract
Background Spinocerebellar ataxias (SCAs) are a group of autosomal dominantly inherited degenerative diseases. As the 
pathological process probably commences years before the first appearance of clinical symptoms, preclinical carriers of a 
SCA mutation offer the opportunity to study the earliest stages of cerebellar dysfunction and degeneration. Eyeblink classical 
conditioning (EBCC) is a motor learning paradigm, crucially dependent on the integrity of the olivocerebellar circuit, and has 
been shown to be able to detect subtle alterations of cerebellar function, which might already be present in preclinical carriers.
Methods In order to acquire conditioned responses, we performed EBCC, delay paradigm, in 18 preclinical carriers of a 
SCA3 mutation and 16 healthy, age-matched controls by presenting repeated pairings of an auditory tone with a supraorbital 
nerve stimulus with a delay interval of 400 ms.
Results Preclinical carriers acquired significantly less conditioned eyeblink responses than controls and learning rates were 
significantly reduced. This motor learning defect was, however, not associated with the predicted time to onset.
Conclusions EBCC is impaired in preclinical carriers of a SCA3 mutation, as a result of impaired motor learning capacities 
of the cerebellum and is thus suggestive of cerebellar dysfunction. EBCC can be used to detect but probably not monitor 
preclinical cerebellar dysfunction in genetic ataxias, such as SCA3.
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Introduction
The dominantly inherited spinocerebellar ataxias (SCAs) are 
progressive neurodegenerative disorders that have cerebel-
lar ataxia as the main clinical theme. Preclinical carriers 
of a SCA mutation can already display subtle symptoms 
suggestive of neuronal dysfunction long before the actual 
manifestation of ataxia (Schols et al. 2004). Such carriers 
thus enable us to study very early stages of cerebellar degen-
eration. Indeed, some studies have demonstrated cerebel-
lar dysfunction in preclinical carriers of a SCA mutation 
(Maas et al. 2015), but this has not led to the availability 
of a simple tool that is able to detect and track cerebellar 
dysfunction at the individual level. Such surrogate markers 
are urgently needed, given the emergence of intervention 
studies in SCAs.
Eyeblink classical conditioning (EBCC) is a tool to assess 
cerebellar-dependent associative learning and has been 
shown to be sensitive to detect subtle cerebellar abnormali-
ties (Bracha et al. 2009; Gerwig et al. 2014).
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This is tested for by presenting repeated pairings of a 
conditioned stimulus (CS; most commonly an auditory or 
visual stimulus) and an unconditioned stimulus (US; usually 
an electrical stimulus or air puff to the eye), the latter giv-
ing rise to reflexive eyelid closure (unconditioned response, 
UR). Owing to intact cerebellar motor learning capac-
ity, healthy individuals eventually display a conditioned 
response (CR; eyelid closure) before onset of the US. The 
underlying cellular mechanisms of eyeblink conditioning are 
a matter of current debate. Purkinje cells in the cerebellar 
cortex show a spontaneous firing pattern. This pattern can be 
modulated, for instance, by conditioning, which leads to sup-
pression of activity of the Purkinje cells, resulting in a pause 
of the firing pattern due to learning. As a result, there is less 
tonic inhibition of the deep cerebellar nuclei that allows for a 
CR to occur. Recent studies show that the underlying plastic-
ity goes beyond long-term depression (LTD) at the parallel 
fiber–Purkinje cell synapse. A more complex mechanism 
involving intrinsic cellular timing also is involved in cerebel-
lar learning (Johansson et al. 2015; Koekkoek et al. 2003; 
McCormick and Thompson 1984; Schonewille et al. 2011; 
ten Brinke et al. 2015; Thompson and Steinmetz 2009).
Studies examining EBCC in patients with degenera-
tive ataxias or cerebellar infarction show a significantly 
decreased incidence and earlier onset of conditioned 
responses (CRs) (Dimitrova et al. 2008; Gerwig et al. 2003; 
Perrett et al. 1993; Timmann et al. 2005). It is, however, 
unknown whether acquisition and timing of CRs are already 
impaired at the preclinical stage of SCAs. In this study, we 
characterized EBCC behavior in preclinical carriers of a 
SCA3 mutation. SCA3 is most common dominant ataxia 
worldwide and the causative mutation is an expanded CAG 
repeat in the ATXN3 gene. Based on the currently available 
literature, we expected EBCC to be abnormal, but we also 
wished to evaluate whether this tool could serve as a sur-
rogate marker of disease evolution (Maas et al. 2015).
Methods
Subjects
Eighteen preclinical carriers with a proven ATXN3/SCA3 
mutation and sixteen healthy age-matched controls were 
included. Carriers were classified as preclinical by an unre-
markable neurological examination and a SARA [Scale 
for the Assessment and Rating of Ataxia, 0 (no ataxia)–40 
(severe ataxia)] score of < 3 (Schmitz-Hubsch et al. 2006).
Exclusion criteria were symptoms indicating disease 
onset such as gait ataxia and/or a SARA score of ≥ 3, a prior 
history of any neurological disorder, hearing impairment, or 
use of centrally acting medication. The study was in accord-
ance with the Declaration of Helsinki and carried out with 
approval of the local ethics committee. All subjects gave 
written informed consent.
Eyeblink conditioning
The conditioning stimulus (CS) was an auditory tone (80 
dB) presented through binaural headphones, lasting 400 ms. 
According to a short delay conditioning paradigm, an elec-
trical stimulus with a duration of 200 µs (stimulus width) to 
the right supraorbital nerve (unconditioned stimulus, US) 
was given 400 ms after the CS onset.
The US was generated by a Digitimer DS7A (Digitimer 
Ltd) that stimulated the right supraorbital nerve through a 
pair of Kendall H59P electrodes (cathode in supraorbital 
foramen, anode 2 cm above cathode).
The stimulus levels were set at 7–10 times the sensory 
threshold for the electrical pulse (Blumenthal et al. 2005; 
Hoffland et  al. 2012). The electrical stimuli intensities 
ranged from 8.0 to 32.0 mA. The paradigm comprised six 
learning blocks of 11 trials: trial 1–9 were CS–US pairs, trial 
10 was US only and trial 11 was CS only. A final, seventh 
block of 11 CS-only trials was included to assess extinction. 
Electromyographic (EMG) activity was recorded from both 
orbicularis oculi muscles.
Data and statistical analysis
EMG registrations of the orbicularis oculi muscle ipsilat-
eral to the US were analyzed manually. An EMG burst was 
considered to be a CR in the interval of 150–400 ms after 
a CS in paired CS–US trials and 150–600 ms after a CS 
in CS-only trials. In addition, this burst had to last more 
than 50 ms or be merged into a superimposed blink reflex 
(unconditioned response, UR, elicited by the US). These 
bursts were distinguished visually. Peak latency of a CR and 
UR were measured for the largest amplitude peak of EMG 
activity with Spike2 software (Cambridge Electronic Design 
Limited, UK, version 8).
EMG activity within 150 ms after the CS was regarded 
as an ‘alpha blink’ (startle response) (supplementary data, 
Figure S1: example of EMG recording).
To analyze CRs, ANOVA was used with BLOCK 
(Block1, Block2, Block3, Block4, Block5, Block6) as 
within-subject factor and GROUP (carriers, controls) as 
between-subject factor. Because of the non-normal distribu-
tion of the data (P value Kolmogorov–Smirnov test < 0.05), 
non-parametric tests (Friedman ANOVA and Mann–Whit-
ney U tests) were used to analyze acquisition in and differ-
ences between both groups. To assess whether extinction 
had occurred, the percentages of CRs in blocks 6 and 7 in 
each group were compared by means of a Chi-square test. In 
this analysis, only participants that showed at least one CR 
in the extinction block were included (Gerwig et al. 2006).
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To compare means of peak latency of both CR and UR, 
onset latency of CR, and the number of alpha responses 
between groups, we used unpaired t tests and Mann–Whit-
ney U tests, depending on the distribution of data.
Furthermore, correlations between percentage of CRs in 
blocks 1–6 and the number of CAG-repeats, SARA score, 
and time to manifestation (TTM) were assessed. TTM was 
determined by subtracting current age from predicted age at 
onset. The latter was calculated using the formula (van de 
Warrenburg et al. 2005):
All statistical analyses were conducted using SPSS for 
Windows (version 22) and significance level was set at 0.05.
Results
Participant characteristics are summarized in Table 1. Fig-
ure 1 displays the acquisition of CRs in both groups. The 
controls showed a significant learning curve, reflected by an 
increase of CR percentage during the six learning blocks (X2 
(5) = 43.94, p < 0.001), while there was only a trend towards 
such a block effect for preclinical carriers (X2 (5) = 10.14, 
Log10(age at onset) = 3.18 − 0.022 ⋅ number of CAG-repeats.
p = 0.07). Significant differences between carriers and con-
trols could be demonstrated in total CR percentage over six 
blocks (U = 76.5, Z = − 2.33, p = 0.02) as well as in mean 
CR percentage in each block, except for the first.
Timing of CRs did not differ significantly between 
both groups (supplementary data). To exclude underlying 
pathology in the response output circuitry, timing of UR 
was assessed and shown to be not significantly different 
(U = 140.0, Z = − 0.14, p = 0.89).
Peak timing and onset of CRs are plotted in Fig. 2. No 
significant difference was found between carriers and con-
trols in these timing aspects of the CRs.
Of all subjects, 7 carriers and 11 controls showed at least 
one CR in the extinction block. In both groups, significant 
extinction occurred (p = 0.008 and p = 0.046, respectively). 
However, more CRs in the extinction block were seen in 
controls. Since extinction is likely not complete after one 
block in controls, it is possible that they are on a higher level 
of extinction than carriers.
A trend towards significance was found in the number of 
alpha blinks, with a lower frequency in preclinical carriers 
(p = 0.06). There was no significant increase in alpha blinks 
over six blocks in both groups.
Table 1  Characteristics of preclinical SCA3 mutation carriers and controls
NA not applicable
Carriers (n = 18) Controls (n = 16) p value
Age 37.7 years (SD 9.7, range 24–61) 38.5 years (SD 11.1, range 23–58) 0.82
Gender 9M/9F 10M/6F 0.46
SARA score 1.4 (SD 1.0, range 0–2.5) 0.3 (SD 0.4, range 0–1) < 0.05
Time to manifestation 15.8 years (SD 10.6, range − 1.5 to 31) NA
Number of CAG-repeats 66 (SD 2.9, range 62–71) NA
Fig. 1  The percentages of con-
ditioned responses in each block 
of testing (including block 7, 
the extinction block, indicated 
by black arrow) are shown for 
preclinical SCA3 mutation 
carriers (black triangles) and 
controls (blank squares). Mean 
percentage CR incidence over 
the six acquisition blocks is also 
shown in a bar diagram on the 
right to visualize overall per-
formance. Error bars represent 
standard deviation. *p < 0.05 
and **p < 0.005. CR condi-
tioned responses
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Mean percentage of CRs in block 1–6 was 26.4% (SD 
27.7) in carriers and 52.4% (SD 34.8) in controls. It is 
known that also amongst healthy controls there are poor 
performers or non-learners. We therefore subdivided the 
groups into learners, which were defined as subjects with 
a total CR percentage above the mean CR incidence minus 
one SD, and non-learners who performed below the afore-
mentioned criterion (Ernst et al. 2016). Eight out of 18 car-
riers (44.4%) were non-learners versus 3 out of 16 controls 
(18.7%), p = 0.1.
There was no significant correlation between the num-
ber of CRs in blocks 1–6 and SARA score (r = − 0.18, 
p = 0.47), CAG-repeat number (r = − 0.15, p = 0.56), or TTM 
(r = 0.08, p = 0.75) for the total group of carriers, nor when 
subdivided into learners and non-learners (Learners: SARA 
score (r = − 0.42, p = 0.3), CAG-repeat number (r = 0.01, 
p = 0.98), or TTM (r = 0.28, p = 0.49); non-learners: SARA 
score (r = − 0.09, p = 0.79), CAG-repeat number (r = 0.52, 
p = 0.12), or TTM (r = − 0.0.09, p = 0.79). It is noteworthy 
that EBCC was abnormal in some carriers that had a pre-
dicted TTM of more than 20 years (supplementary data, 
Figure S2).
Discussion
Our study shows that the delay paradigm of EBCC is at 
group level impaired in preclinical carriers of a SCA3 muta-
tion. The group of carriers displayed a lower mean number 
of CRs and a reduced learning effect was established over 
the consecutive blocks compared to controls. These results 
suggest that cerebellar learning is already impaired in the 
preclinical stages of SCA3, providing an objective measure 
of cerebellar dysfunction in this phase.
Since SCA3 is a slowly progressive neurodegenerative 
disease the degenerative process has already started in the 
preclinical phase of the disease. Histological studies in 
SCA3 patients show degeneration of the deep cerebellar 
nuclei. Mainly neuronal loss in the dentate nucleus with 
relative preservation of the cerebellar cortex is seen, in con-
trast to other spinocerebellar ataxias (Koeppen et al. 2013; 
Scherzed et al. 2012). The involvement of these nuclei in 
the pathology underlying SCA3 is the likely cause of the 
impaired EBCC in preclinical carriers.
Several animal studies show that intact function of the 
interposed nuclei is needed for adequate conditioning in 
EBCC. For instance, very small, localized lesions of the 
interposed nucleus in rabbits completely abolished CR 
acquisition (Steinmetz et al. 1992). Furthermore, cooling 
of the interposed nucleus, temporarily impairing its func-
tion, lead to disruption of previously acquired CRs in rab-
bits. After warming the interposed nucleus back to normal 
temperature, restoring its function, CRs re-occurred (Clark 
et al. 1992).
In healthy humans, a 7T functional MRI study showed a 
concurrent increase in blood oxygenation level-dependent 
(BOLD) activity of the cerebellar nuclei as well as of the 
cerebellar cortex in the early phase of acquisition of CRs. 
Activation was mainly seen in lobules VI of the cerebellar 
cortex, the interposed nuclei, and also to a lesser extend 
Fig. 2  Onset and peak timing of conditioned responses (CR) are shown on the y axis. Data are plotted for carriers (black) and controls (grey). 
Error bars represent standard deviation
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in the dentate nuclei (Thurling et al. 2015). This suggests 
an additional contribution of the lateral cerebellum, which 
projects to the deep cerebellar nuclei, and of the dentate in 
human EBCC. In SCA3, SWI sequences showed a volume 
reduction of the dentate nuclei on 7T brain MRI. This 
is in accordance with the involvement of the dentate in 
SCA3 as seen in neuropathological studies (Stefanescu 
et al. 2015). Therefore, our data could suggest that the 
cerebellar nuclei, in particular the dentate and interposed 
nuclei, are possibly undergoing early neuronal dysfunction 
or degeneration in SCA3, as shown by impaired EBCC in 
preclinical carriers.
Abnormal EBCC has also been demonstrated in patients 
with symptomatic cerebellar disease. Previous studies have 
shown that cerebellar degeneration and lesions lead to 
impaired acquisition of CRs. A patient with primary cer-
ebellar agenesis acquired only a very low percentage of CRs 
despite 7 days of extensive training (Wu et al. 2018). Patients 
with cerebellar degeneration showed a prominently reduced 
number of CRs and a smaller learning effect over consecu-
tive blocks compared to controls. These findings were less 
severe in patients with focal cerebellar lesions, but acqui-
sition of CRs was still significantly reduced compared to 
healthy controls (Ernst et al. 2016; Gerwig et al. 2010; Yeo 
et al. 1985). The preclinical carriers in our study showed 
similar results with EBCC, although to a less severe extent 
at the group level. Compared to controls, they acquired a 
lower number of CRs and cerebellar learning was also lim-
ited compared to healthy non-carriers. However, at the indi-
vidual level, some carriers still displayed normal condition-
ing, whilst others showed impairment comparable to results 
found in patients with symptomatic cerebellar disease. This 
suggests that impairment of EBCC is likely a static trait, in 
which EBCC is either disturbed or normal in subjects with 
a certain level of cerebellar dysfunction, instead of a marker 
of gradual decline.
There was no correlation between the calculated time 
to manifestation and acquisition of CRs. There might be 
variability in the point in time when certain sets of neurons, 
such as those crucial for the EBCC circuitry, start to be dys-
functional in the long preclinical window. Other genetic, 
environmental, and compensatory mechanisms are important 
contributing factors to such variability (Falcon et al. 2016). 
We saw clearly abnormal EBCC even in some carriers with 
a predicted time to onset of more than 20 years, and con-
versely normal EBCC in some who were close to their pre-
dicted onset. Assuming that EBCC will never improve once 
abnormal, this also supports our hypothesis that abnormal 
EBCC would be a static trait, present after exceeding of a 
certain threshold of dysfunction or degeneration. This is in 
accordance with another study in patients with cerebellar 
degeneration that found only weak correlations between 
clinical ataxia scores and impaired learning with EBCC and 
the absence of significant worsening over a 1-year follow-up 
(Timmann et al. 2005).
In contrast to symptomatic patients with degenerative 
cerebellar ataxia, timing of CRs and extinction were not 
impaired in preclinical SCA3 mutation carriers (Gerwig 
et al. 2005). In rabbits, lesions of the cerebellar cortex dis-
turbed the timing of CRs, especially lesions of the anterior 
lobe (Perrett et al. 1993). Patients with dyslexia with sus-
pected mild cerebellar dysfunction showed, despite normal 
acquisition and amplitudes of CRs, disturbed timing. This 
finding suggests possible separate mechanisms for acquisi-
tion versus timing of CRs (Nicholson and Freeman 2002). 
An accurately timed CR is depended on the processes of 
long-term depression and long-term potentiation, but it 
is still not clear how this exactly leads to adequate timing 
(Freeman and Muckler 2003; Racine et al. 1986). Possibly, 
a temporal relation between the input of the climbing fib-
ers causing depression or potentiation lead to an activity 
peak in the granule cells, with the same temporal pattern 
after learning. This then will lead to an adequately timed 
CR (Johansson et al. 2014). Since we did not find disturbed 
timing of CRs, but rather a lower number of acquired CRs, 
acquisition and timing seem to be two distinct processes that 
can be affected independently.
Extinction was normal in preclinical carriers compared 
to controls. In patients with focal cerebellar lesions or pure 
cortical cerebellar degeneration and diminished acquisition 
of CRs, extinction was found to be impaired (Gerwig et al. 
2006). This finding was challenged by a more recent study 
that showed that in patients with focal cerebellar lesions 
with sufficient acquisition of CRs (learners) to evaluate 
extinction, this process was intact, whilst in the majority 
of patients the number of acquired CRs was too low (non-
learners) to draw conclusions about the extinction phase 
(Ernst et al. 2016). Some studies suggest a cortical process 
for extinction at the level of Purkinje cells, within an intact 
cerebellar network (Jirenhed et al. 2007). Since in SCA3 the 
cerebellar cortex is relatively spared, normal extinction in 
SCA3 carriers found in our study could favor the hypothesis 
of an important role of the cerebellar cortex in extinction.
For unconditioned responses (UR), animal studies show 
contrasting results, but in humans with cortical lesions of 
the superior cerebellum, increased duration and amplitudes 
of unconditioned responses were found. In our study, we 
did not find a difference in UR timing between carriers and 
controls. This may indicate that this region is not affected in 
presymptomatic carriers and that cerebellar dysfunction is 
responsible for the abnormalities in alpha blinks and CRs in 
carriers, and that there is no other ‘driver’ of these results.
A possible limitation is the inclusion of a relatively small 
number of subjects; it is therefore difficult to draw definite 
conclusions about for example extinction. But since SCA3 
is a rare disease, and presymptomatic carriers are not very 
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frequently identified, the total number of carriers included in 
this study is sufficient to study EBCC in this group.
In conclusion, our study provides evidence of abnormal 
cerebellar motor learning in the preclinical stage of SCA3 
mutation carriers and demonstrates that the delay paradigm 
of EBCC is a relatively simple tool to assess this. How-
ever, at the individual level, there is variability in EBCC 
performance among carriers, irrespective of predicted time 
to disease onset. Therefore it can be mainly used to assess 
performance at group level, similar to patients with symp-
tomatic cerebellar disease who also show variability in the 
level of conditioning. This, combined with the notion that 
abnormal EBCC is very likely a static trait, questions its util-
ity as a surrogate marker in future treatment trials targeting 
(preclinical) carriers of a SCA3 mutation.
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